Unknown PHASE1 INTERVENTIONAL 2-arm NCT00865683

DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)

DHA, Inflammation, and Insulin Sensitivity

Sponsor: Mead Johnson Nutrition

Conditions Diabetes, Gestational Hypertension in Pregnancy Insulin Resistance Overweight and Obesity Pre-Eclampsia

Interventions DHA Supplements Placebo Supplements

Updated 6 times since 2017 Last updated: Jul 14, 2009 Started: Apr 30, 2009 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Diabetes, Gestational and Hypertension in Pregnancy and is currently ongoing. Mead Johnson Nutrition leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Mar 2026 — Present [monthly]

Unknown PHASE1
Sep 2024 — Mar 2026 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mead Johnson Nutrition
National Heart, Lung, and Blood Institute (NHLBI)
Office of Research on Women's Health (ORWH)
dsm-firmenich Switzerland AG

Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States